107 related articles for article (PubMed ID: 488332)
1. [Antitumor and immunodepressive action of dexamethasone on a leukemia L-1210 model].
Berezina TA; Uteshev BS; Babichev VS
Farmakol Toksikol; 1979; 42(5):537-41. PubMed ID: 488332
[TBL] [Abstract][Full Text] [Related]
2. [Comparative characteristics of the antitumor and immunodepressive activity of carminomycin on the L-1210 experimental model].
Berezina TA; Uteshev BS
Antibiotiki; 1979 Oct; 24(10):767-71. PubMed ID: 496420
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of antineoplastic and immunosuppressive properties of ftorafur].
Nosova TA; Babichev VA; Uteshev BS
Farmakol Toksikol; 1976; 39(5):589-93. PubMed ID: 800767
[TBL] [Abstract][Full Text] [Related]
4. [Dynamics of the immunodepressive and antitumor activity of adriamycin].
Vereina TL; Turishchev VE; Gavrilova AD; Matveev AB
Farmakol Toksikol; 1986; 49(1):73-5. PubMed ID: 3948992
[TBL] [Abstract][Full Text] [Related]
5. [Immunodepressant action of cyclophosphamide in different strains of mice].
Pevnitskiĭ LA; Telegin LIu; Bol'shev VN
Biull Eksp Biol Med; 1977 Apr; 83(4):438-40. PubMed ID: 558023
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
Phelan ET; Vietti TJ; Valeriote FA; Coulter D
Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
[TBL] [Abstract][Full Text] [Related]
7. [The immunodepressive and lympholytic action of kortifen].
Pykhtina AA; Gladkova NE
Farmakol Toksikol; 1988; 51(5):72-4. PubMed ID: 3208888
[TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of the antitumor action of spirobromine in mice with leukemia P-388].
Sokolova IS; Riabokon' NA; Chernov VA; Gorbacheva LB
Izv Akad Nauk SSSR Biol; 1989; (5):660-5. PubMed ID: 2584530
[TBL] [Abstract][Full Text] [Related]
9. Antitumor and immunosuppressive effects of mycophenolic acid derivatives.
Ohsugi Y; Suzuki S; Takagaki Y
Cancer Res; 1976 Aug; 36(8):2923-7. PubMed ID: 1277202
[TBL] [Abstract][Full Text] [Related]
10. [Pyrrolo(3,2-d)pyrimidines as potential antitumor agents].
Kravchenko AI; Chernov VA; Shcherbakova LI; Filitis LN; Pershin GN
Farmakol Toksikol; 1979; 42(6):659-65. PubMed ID: 499477
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of both leukemic and normal cell population reduction following 5-azacytidine.
Presant CA; Vietti T; Valeriote F
Cancer Res; 1975 Aug; 35(8):1926-30. PubMed ID: 50128
[TBL] [Abstract][Full Text] [Related]
12. [Possibility of utilizing lymphatic leukemia L1210 as a first screening model in the primary selection of new antitumor antibiotics].
Shorin VA; Bazhanov VS
Antibiotiki; 1974 Aug; 19(8):679-84. PubMed ID: 4455117
[No Abstract] [Full Text] [Related]
13. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
Guo QL; Wu MS; Chen Z
Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide. I. Effects of survival and colony-forming cells in BDF1 L-1210-bearing mice.
Pazdernik TL; Uyeki EM
J Pharmacol Exp Ther; 1978 Oct; 207(1):255-61. PubMed ID: 702348
[TBL] [Abstract][Full Text] [Related]
16. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
Ujiie T
Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
[TBL] [Abstract][Full Text] [Related]
17. [Experiment to potentiate the effect of cyclophosphamide combined with tempidon and caffeine in leukemia L1210 and Lewis hepatic carcinoma].
Stoichkov I; Milushev A; Todorov D
Eksp Med Morfol; 1978; 17(1):9-14. PubMed ID: 639751
[TBL] [Abstract][Full Text] [Related]
18. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
Fuji H; Mihich E
Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.
Flora KP; van't Riet B; Wampler GL
Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062
[TBL] [Abstract][Full Text] [Related]
20. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
